Trial Information

Summary: Mantle Cell Lymphoma (MCL) - relapsed refractory

Wyeth Research is currently recruiting subjects to participate in an experimental study for subjects with Mantle Cell Lymphoma (MCL), that compares the effectiveness and safety of a study drug compared to the study doctor’s available therapy choices.

To qualify, you must:

• Have a confirmed diagnosis of Mantle Cell Lymphoma (MCL)
• Have received 2 to 7 prior therapies, and be in a refractory or relapsed state
• Have adequate organ and bone marrow function
• Be at least 18 years of age
• Have a life expectancy of at least 3 months

You will not qualify if you:

• Have a history of other cancers in the last 5 years
• Have another type of cancer other than MCL
• Have active spread of your cancer to the central nervous system
• Have had prior investigational therapy within 3 weeks of first dose
• Have had chemotherapy, radiotherapy, immunotherapy or major surgery within 3 weeks of study start, or radioimmunotherapy within 8 weeks of study start.
• Have uncontrolled current illnesses
• Are a subject with a weakened immune system
• Are a female subject that is pregnant or breast feeding

For more information,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:58 AM